| Primary information |
|---|
| ID | antitb_1549 |
| Peptide Name | NisinA |
| Sequence | I-(Dhb)-A-I-D-L-A-(Dha)-P-G-A-K-(Abu)-G-A-L-M-G-A-N-M-K-(Abu)-A-(Abu)-A-N-S-I-H-V-(Dha)-L |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | Dha= Didehydroalanine, Dhb= Didehydroaminobutyric acid, Abu= 2-aminobutyric acid |
| Linear/ Cyclic | Linear |
| Length | 33 |
| Chirality | L |
| Nature | Cationic |
| Source | NA |
| Origin | NA |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis H37Rv |
| Inhibition Concentartion | MIC = 60 μg/ml |
| In vitro/In vivo | in vitro |
| Cell Line | NA |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 25613372 |
| Year of Publication | 2015 |
| 3-D Structure | NA |